In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples